Iridoids as a Potential Hepatoprotective Class: A Review

Author:

de Carvalho Meirelles Gabriela1,Bridi Raquel2,von Poser Gilsane Lino1

Affiliation:

1. Laboratório de Farmacognosia, Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, 90610-000, Porto Alegre/RS, Brazil

2. Departamento de Química Farmacológica y Toxicológica, Facultad de Ciências Químicas y Farmacéuticas, Universidad de Chile, Santiago, 8380000, Chile

Abstract

Background: Liver disease rates are gradually increasing over the years, becoming a severe public health problem. The indiscriminate use of drugs associated with a rich fat diet, high consumption of alcoholic beverages, and exposure to viral infections and lipid peroxidative products are considered the chief factors for developing hepatic disorders. Owing to the absence of reliable hepatoprotective drugs in the therapeutic arsenal, since they present a high incidence of adverse reactions and/or lack of efficacy in some cases, liver diseases are widely treated with medicinal plants. Among them are the plants producing iridoids, which are believed to be good remedies for liver disease due to their bitter taste. The hepatoprotective effect of iridoids and extracts, rich in these compounds, has been demonstrated, both in vitro and in vivo. Objective: This review aims to scrutinize the available literature related to the hepatoprotective activity of iridoids. Methods: The information was obtained from scientific databases (Science Direct, PubMed, Web of Science, Scopus, ACS Publications, Wiley Online Library) until December, 2021. Results and Conclusion: A total of 63 hepatoprotective iridoids were found, including aucubin, catalpol and picroliv, a mixture of two iridoids. They are the target of a high number of studies, which revealed their protective action against different hepatotoxic agents and detailed action mechanisms. Results and Conclusion: A total of 63 hepatoprotective iridoids were found, including aucubin, catalpol and picroliv, a mixture of two iridoids. They are the target of a high number of studies, which revealed their protective action against different hepatotoxic agents and detailed action mechanisms.

Funder

FAPERGS

CAPES and CNPq

Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology,General Medicine

Reference148 articles.

1. Trefts E.; Gannon M.; Wasserman D.H.; The liver. Curr Biol 2017,27(21),R1147-R1151

2. Udompap P.; Kim D.; Kim W.R.; Current and future burden of chronic nonmalignant liver disease. Clin Gastroenterol Hepatol 2015,13(12),2031-2041

3. Asrani S.K.; Devarbhavi H.; Eaton J.; Kamath P.S.; Burden of liver diseases in the world. J Hepatol 2019,70(1),151-171

4. Sepanlou S.G.; Safiri S.; Bisignano C.; Ikuta K.S.; Merat S.; Saberifiroozi M.; Poustchi H.; Tsoi D.; Colombara D.V.; Abdoli A.; Adedoyin R.A.; Afarideh M.; Agrawal S.; Ahmad S.; Ahmadian E.; Ahmadpour E.; Akinyemiju T.; Akunna C.J.; Alipour V.; Almasi-Hashiani A.; Almulhim A.M.; Al-Raddadi R.M.; Alvis-Guzman N.; Anber N.H.; Angus C.; Anoushiravani A.; Arabloo J.; Araya E.M.; Asmelash D.; Ataeinia B.; Ataro Z.; Atout M.M.D.W.; Ausloos F.; Awasthi A.; Badawi A.; Banach M.; Bejarano Ramirez D.F.; Bhagavathula A.S.; Bhala N.; Bhattacharyya K.; Biondi A.; Bolla S.R.; Boloor A.; Borzì A.M.; Butt Z.A.; Cámera L.L.A.; Campos-Nonato I.R.; Carvalho F.; Chu D.T.; Chung S.C.; Cortesi P.A.; Costa V.M.; Cowie B.C.; Daryani A.; de Courten B.; Demoz G.T.; Desai R.; Dharmaratne S.D.; Djalalinia S.; Do H.T.; Dorostkar F.; Drake T.M.; Dubey M.; Duncan B.B.; Effiong A.; Eftekhari A.; Elsharkawy A.; Etemadi A.; Farahmand M.; Farzadfar F.; Fernandes E.; Filip I.; Fischer F.; Gebremedhin K.B.B.; Geta B.; Gilani S.A.; Gill P.S.; Gutirrez R.A.; Haile M.T.; Haj-Mirzaian A.; Hamid S.S.; Hasankhani M.; Hasanzadeh A.; Hashemian M.; Hassen H.Y.; Hay S.I.; Hayat K.; Heidari B.; Henok A.; Hoang C.L.; Hostiuc M.; Hostiuc S.; Hsieh V.C.; Igumbor E.U.; Ilesanmi O.S.; Irvani S.S.N.; Jafari Balalami N.; James S.L.; Jeemon P.; Jha R.P.; Jonas J.B.; Jozwiak J.J.; Kabir A.; Kasaeian A.; Kassaye H.G.; Kefale A.T.; Khalilov R.; Khan M.A.; Khan E.A.; Khater A.; Kim Y.J.; Koyanagi A.; La Vecchia C.; Lim L-L.; Lopez A.D.; Lorkowski S.; Lotufo P.A.; Lozano R.; Magdy Abd El Razek M.; Mai H.T.; Manafi N.; Manafi A.; Mansournia M.A.; Mantovani L.G.; Mazzaglia G.; Mehta D.; Mendoza W.; Menezes R.G.; Mengesha M.M.; Meretoja T.J.; Mestrovic T.; Miazgowski B.; Miller T.R.; Mirrakhimov E.M.; Mithra P.; Moazen B.; Moghadaszadeh M.; Mohammadian-Hafshejani A.; Mohammed S.; Mokdad A.H.; Montero-Zamora P.A.; Moradi G.; Naimzada M.D.; Nayak V.; Negoi I.; Nguyen T.H.; Ofori-Asenso R.; Oh I-H.; Olagunju T.O.; Padubidri J.R.; Pakshir K.; Pana A.; Pathak M.; Pourshams A.; Rabiee N.; Radfar A.; Rafiei A.; Ramezanzadeh K.; Rana S.M.M.; Rawaf S.; Rawaf D.L.; Reiner R.C.; Roever L.; Room R.; Roshandel G.; Safari S.; Samy A.M.; Sanabria J.; Sartorius B.; Schmidt M.I.; Senthilkumaran S.; Shaikh M.A.; Sharif M.; Sharifi A.; Shigematsu M.; Singh J.A.; Soheili A.; Suleria H.A.R.; Teklehaimanot B.F.; Tesfay B.E.; Vacante M.; Vahedian-Azimi A.; Valdez P.R.; Vasankari T.J.; Vu G.T.; Waheed Y.; Weldegwergs K.G.; Werdecker A.; Westerman R.; Wondafrash D.Z.; Wondmieneh A.B.; Yeshitila Y.G.; Yonemoto N.; Yu C.; Zaidi Z.; Zarghi A.; Zelber-Sagi S.; Zewdie K.A.; Zhang Z-J.; Zhao X-J.; Naghavi M.; Malekzadeh R.; The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020,5(3),245-266

5. Farzaei M.H.; Zobeiri M.; Parvizi F.; El-Senduny F.F.; Marmouzi I.; Coy-Barrera E.; Naseri R.; Nabavi S.M.; Rahimi R.; Abdollahi M.; Curcumin in liver diseases: A systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients 2018,10(7),E855

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3